WAM
ANIP icon

Wellesley Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

Wellesley Asset Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-28,500
Closed -$1.28M – 61
2018
Q4 		$1.28M Buy
+28,500
New +$1.49M 0.09% 69

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellesley Asset Management's ANIP Position: Q1 2019 in Review

Wellesley Asset Management sold out of ANI Pharmaceuticals (ANIP) in Q1 2019, closing a stake of 28,500 shares — an estimated $1.28M sold.

Wellesley Asset Management first reported a position in ANIP in Q4 2018 and held it in 1 quarter. The position peaked at $1.28M in Q4 2018. 190 funds tracked by Wall St. Rank hold ANIP as of Q1 2019.

  • Wellesley Asset Management reported no remaining ANI Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Wellesley Asset Management sold 28,500 ANI Pharmaceuticals shares in Q1 2019, an estimated $1.28M.
  • Wellesley Asset Management first reported a position in ANI Pharmaceuticals in Q4 2018 and held it in 1 quarter.
  • Wellesley Asset Management's ANI Pharmaceuticals position peaked at $1.28M in Q4 2018.
  • 190 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2019.

Based on Wellesley Asset Management's 13F filing for Q1 2019, filed 7 May 2019.